Page 3 - Yihai Cao News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Yihai cao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Yihai Cao Today - Breaking & Trending Today
A small clinical study in Italy and China has revealed that an anticancer drug bevacizumab could help mitigate mortality and boost recovery from the novel coronavirus.The study was carried out b ....
LONDON Treating severe Covid-19 patients with an anticancer drug may reduce mortality and speed up recovery, a new study suggests. According to a small clinical study, published in the journal Natur ....
Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. ....
Date Time Anticancer drug may improve outcome for severe COVID-19 patients Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. On average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients treated with a single dose of bevacizumab in addition to standard care. The research is published in Nature Communications. Yihai Cao, photo: Ulf Sirborn “To reduce COVID-19 mortality, we aim to develop an effective therapeutic paradigm for treating patients with severe COVID-19,” says corresponding author Yihai Cao, professor of vascular biology at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet. “Our findings suggest that bevacizumab plus standard care is highly beneficial for patien ....